Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 169   

Articles published

GSK 1,331.00 +56.50 (4.43%)
price chart
Why Growth Is Expected To Take Off At GlaxoSmithKline plc, Barclays PLC ...
Thanks to the effect of enduring patent losses across key labels, GlaxoSmithKline (LSE: GSK) is not expected to see the bottom line light up any time soon.
Head To Head: Barclays plc vs GlaxoSmithKline plc
But if chosen well, your portfolio of shares could appreciate strongly once confidence returns to shares. The question is, what should you buy?
Should You Protect Your Portfolio With Defensive Stocks National Grid plc ...
With stock markets extending last week's losses, investors could reduce their risks by shifting into defensive shares. Having a mix of defensive and cyclical shares in your investment portfolio could help to reduce the volatility of your investment ...
Large Outflow of Money Witnessed in GlaxoSmithKline PLC
GlaxoSmithKline PLC (NYSE:GSK) traded higher in the last at $39.7, gaining 0.29 points or 0.74%. From the data available, it can be said that the stock did not make an impact in the money flow department with the net figure coming to be $(-3.62) million.
GlaxoSmithKline PLC (NYSE:GSK) Given PT Range of $45-$52  Markets Daily
Could Neil Woodford Be Wrong About GlaxoSmithKline plc And AstraZeneca plc?
Neil Woodford is one of AstraZeneca (LSE: AZN) GlaxoSmithKline's (LSE: GSK) most vocal supporters. The star fund manager has sung the praises of Astra and Glaxo's management many times over, and he commended Astra's decision to turn down US ...
Is Pfizer Inc. Considering A �19-Per-Share Offer For GlaxoSmithKline plc?
GlaxoSmithKline's (LSE: GSK) shares have been on fire this week, outpacing the wider FTSE 100 by more than 3% over the past five days.
3 Reasons To Buy GlaxoSmithKline plc And Sell Quindell PLC Today
GlaxoSmithKline (LSE: GSK) and Quindell (LSE: QPP) are both heavily traded by private investors. But that's where the similarity ends.
Don't Make These Basic Mistakes With GlaxoSmithKline plc, ARM Holdings plc ...
Pharmaceuticals giant GlaxoSmithKline has long been a favourite with income investors. The table below shows some dividend information currently being displayed by 4-Traders, one of a number of sites (including the FT) supplied by Thomson Reuters.
Is GlaxoSmithKline plc A Better Buy Than Smith & Nephew plc And Hikma ...
For investors in Smith & Nephew (LSE: SN) and Hikma (LSE: HIK), the last five years have been superb. That's because the two health care companies have posted share price gains of 107% and 224% respectively, which is well ahead of the FTSE 100's rise ...
Sanford C. Bernstein Reiterates Market Perform Rating for GlaxoSmithKline plc ...
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “market perform” rating reissued by equities researchers at Sanford C. Bernstein in a research report issued to clients and investors on Wednesday, MarketBeat reports.
GlaxoSmithKline plc Stock Rating Reaffirmed by JPMorgan Chase & Co. (GSK)  WKRB News
GlaxoSmithKline plc 2.3% Potential Upside Indicated by JP Morgan Cazenove  DirectorsTalk Interviews